Study at a glance
What is the difference between free and total vitamin D?
For 25-hydroxyvitamin D, the form used in the usual blood test, the total result includes amounts attached to proteins and amounts not attached to proteins. Free means only the small amount that is not attached. Changes in carrier proteins can affect these measurements differently.
Can laboratory methods create an apparent difference between groups?
Yes. A widely used carrier-protein test detected some inherited protein forms less well than others. This distorted comparisons between groups and affected calculations that used those results to estimate free vitamin D.
Is calculated free vitamin D the same as a direct measurement?
No. A calculated result relies on other test values and assumptions about how vitamin D attaches to proteins. Errors in those inputs can affect the estimate.
Is free vitamin D always a better test?
No. Free and total values often follow a similar pattern, and total remains useful as a general check of vitamin D supply. When carrier-protein levels are unusual, more context may be needed to understand the result. Neither result directly measures vitamin D activity in every tissue.
Read the full article below ↓Vitamin D-binding protein does more than carry vitamin D through blood. Because most circulating 25-hydroxyvitamin D, or 25(OH)D, is protein-bound, variation in DBP can change what a total blood measurement means. The complication is that not every apparent DBP difference is biological. Some of the most influential genotype and ancestry findings were strongly shaped by the assay used to measure the protein. The evidence therefore has to separate three questions: how much DBP is present, how tightly it binds vitamin D metabolites, and whether the laboratory method measures different DBP variants equally.
Common DBP phenotypes can change total 25(OH)D more than free 25(OH)D
A 12-month randomised supplementation study of 472 participants compared total 25(OH)D, directly measured free 25(OH)D, calculated free 25(OH)D and DBP across common DBP phenotypes. Total 25(OH)D and DBP were lower in people with the Gc2/Gc2 phenotype than in groups carrying Gc1S. The important result was what happened when the investigators looked at free 25(OH)D directly: phenotype differences became much smaller.
The contrast was substantial enough to matter physiologically. The reported difference between Gc2/Gc2 and Gc1S/Gc1S was about 30.2% for total 25(OH)D but only about 9.0% for directly measured free 25(OH)D, and the free difference was no longer statistically significant. Vitamin D supplementation increased vitamin D measures, but it did not materially change DBP concentration, and the supplementation response did not differ significantly across DBP phenotypes.
This does not prove that free 25(OH)D is always the better clinical measure. It shows something narrower and more useful: when the binding-protein concentration differs, total and free measures can shift by different amounts. That is the central physiological reason the distinction in Free vs Total Vitamin D Explained matters.
Calculated free vitamin D depends on the DBP value put into the calculation
Free 25(OH)D can be measured directly or estimated mathematically from total 25(OH)D, albumin, DBP and assumed binding constants. The calculated route therefore inherits the accuracy of every input. If the DBP concentration is wrong, the free estimate can be wrong even when the equation itself is applied correctly.
That vulnerability became important after reports suggested that Black Americans had substantially lower DBP concentrations than White Americans and therefore similar calculated bioavailable vitamin D despite lower total 25(OH)D. The biological interpretation was attractive because it appeared to reconcile a lower total concentration with preserved available vitamin D. Later analytical work showed that the key DBP measurement was not neutral across genetic variants.
Mass spectrometry exposed genotype-sensitive monoclonal assay bias
In genotyped samples from the ARIC cohort, Hoofnagle and colleagues quantified DBP by targeted mass spectrometry and compared the result with the monoclonal immunoassay that had supported the large ancestry-associated difference. The mass-spectrometric measurements did not reproduce the same large genotype pattern. The discrepancy pointed to the antibody assay itself: the monoclonal reagent recognised common DBP isoforms differently.
This matters because Gc1f is more common in people of African ancestry. An assay that under-recovers that isoform can make DBP appear systematically lower in a population even when the true protein concentration is not lower to the same extent. A calculated free-vitamin value built from that underestimated DBP concentration will then be biased upward.
Independent method comparisons reproduced the problem
Denburg and colleagues tested the same issue in a genotyped chronic kidney disease cohort using two ELISA approaches and mass spectrometry. The genotype dependence was far stronger with the monoclonal assay than with polyclonal or mass-spectrometric measurement. The study also showed why this is not merely a laboratory technicality. When biased DBP values were used to estimate bioavailable vitamin D, the apparent genotype differences in the derived vitamin D measures changed as well.
The lesson is not that immunoassays are intrinsically invalid. It is that an antibody method can have variant-dependent recovery, and that this has to be tested before a population difference is interpreted as physiology. The method used to measure the carrier becomes part of the causal chain when the carrier value is then used to calculate free or bioavailable vitamin D.
Direct free measurements changed the ancestry story
A larger cross-sectional study of 1,057 men from the United States, the United Kingdom and The Gambia compared directly measured free 25(OH)D with total 25(OH)D and several DBP measurement methods. Total 25(OH)D correlated strongly with directly measured free 25(OH)D, with a Spearman correlation of 0.84.
The DBP result depended sharply on assay architecture. With the monoclonal assay, mean DBP in participants of African ancestry appeared about 50% lower than in White participants. With polyclonal assays or proteomic methods, that large ancestry difference disappeared. Calculated free 25(OH)D based on polyclonal DBP values also correlated strongly with directly measured free 25(OH)D.
The biological conclusion therefore changed. The earlier proposition that lower DBP largely equalised free vitamin D between Black and White Americans was not supported once the genotype-sensitive measurement problem was removed. In this study, African American participants had lower free as well as lower total 25(OH)D than US White participants. The point is not to convert ancestry into a biological vitamin D rule. It is to show that assay bias can manufacture a mechanistic explanation that disappears when the protein is measured by an orthogonal method.
DBP affinity differences are less settled than calculations often imply
Calculated free 25(OH)D also depends on the binding constants assigned to different DBP variants. Historical literature has sometimes used large genotype-specific differences in affinity as though they were fixed physiological constants. That is not secure enough for a universal claim. Direct affinity studies and later comparative reviews have reported no difference or much smaller differences than some earlier estimates.
This uncertainty does not mean GC genotype is irrelevant. Common phenotypes can differ in DBP concentration and total 25(OH)D, as the supplementation study shows. It means the mechanism should not be reduced to a single settled hierarchy in which Gc1f, Gc1s and Gc2 each have one universally accepted affinity that can be inserted into a calculation without qualification.
Pathological low-DBP states show how total and free values can separate
The clearest human demonstration that binding-protein concentration can change the interpretation of total 25(OH)D comes from states in which DBP is genuinely reduced. In liver disease, patients with lower DBP and albumin had lower total 25(OH)D and a higher percentage free fraction, while absolute free 25(OH)D remained comparable with controls. Total 25(OH)D tracked DBP and albumin, whereas free 25(OH)D did not.
Rare congenital DBP deficiency pushes the same principle to an extreme. A patient with homozygous GC deletion had essentially absent DBP and extremely low total vitamin D metabolites, yet maintained normocalcaemia and comparatively preserved mineral physiology. These conditions are not ordinary population variation, but they establish an important boundary: a total 25(OH)D concentration can be strongly influenced by the size of the binding-protein reservoir.
What total and free 25(OH)D each tell us
In ordinary populations, total and free 25(OH)D are often strongly correlated. That is why total 25(OH)D remains useful and why the evidence does not support replacing it universally with a free measurement. The relationship becomes more complicated when DBP concentration is unusually low or high, when genotype is being compared across populations, or when the DBP assay itself has variant-dependent recovery.
The practical scientific distinction is therefore conditional rather than absolute. Total 25(OH)D describes the complete circulating pool, most of which is bound. Free 25(OH)D describes the unbound fraction. DBP concentration and binding behaviour connect the two, while assay architecture determines whether the carrier is being measured accurately enough to support that interpretation. This is also why Vitamin D Status vs Vitamin D Effect cannot be reduced to a single number without considering what that number represents.
Evidence boundaries
- Free 25(OH)D should not be described as universally superior to total 25(OH)D for assessing vitamin D status.
- Race or ancestry should not be used as a surrogate for DBP genotype, DBP concentration, binding affinity or biological vitamin D availability.
- Monoclonal-assay findings known to be genotype-sensitive should not be treated as direct proof of biological DBP concentration differences.
- Large universal genotype-specific DBP affinity constants should not be presented as settled physiology.
- Rare GC-null states and severe liver disease demonstrate what altered binding can do, but they should not be generalised directly to common polymorphisms in otherwise healthy people.
- Similar circulating free 25(OH)D does not by itself prove identical tissue-level vitamin D action.
Primary evidence and publication details
Sollid ST, Hutchinson MYS, Berg V, et al. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. European Journal of Endocrinology. 2016;174:445-452.
Hoofnagle AN, Eckfeldt JH, Lutsey PL. Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry. New England Journal of Medicine. 2015;373:1480-1482.
Denburg MR, Hoofnagle AN, Sayed S, et al. Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes. Journal of Bone and Mineral Research. 2016;31:1128-1136.
Nielson CM, Jones KS, Chun RF, et al. Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations. Journal of Clinical Endocrinology and Metabolism. 2016;101:2226-2234.
Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. Journal of Clinical Investigation. 1986;78:748-752.
Henderson CM, Fink SL, Bassyouni H, et al. Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene. New England Journal of Medicine. 2019;380:1150-1157.
Related reading
A Novel Biomarker Panel to Identify Steroid Resistance in Childhood Idiopathic Nephrotic Syndrome
Idiopathic nephrotic syndrome (NS) is the most common glomerular disorder of childhood.
Original paper ↗Read more →Association of rs4588 polymorphism in vitamin D binding protein gene with polycystic ovarian syndrome in Iranian women: a case-control study
Vitamin D deficiency and variations in the vitamin D binding protein (VDBP) gene may play a role in the development of Polycystic ovary syndrome (PCOS).
Original paper ↗Read more →Association of vitamin D deficiency and VDBP gene polymorphism with the risk of AMI in a Pakistani population
Mean serum concentration of 25(OH) vitamin D was significantly lower in AMI patients compared to healthy subjects (p=0.015) and percent vitamin D deficiency was higher in AMI patients compared to healthy subjects (p=0.003).
Original paper ↗Read more →Causal Relationships Between Epilepsy, Anti‐Epileptic Drugs, and Serum Vitamin D and Vitamin D Binding Protein: A Bidirectional and Drug Target Mendelian Randomization Study
Previous studies suggest potential associations between epilepsy, anti‐epileptic drugs (AEDs), and levels of vitamin D and vitamin D‐binding protein (VDBP).
Original paper ↗Read more →Correlation of Plasma 25(OH)D3 and Vitamin D Binding Protein Levels with COVID-19 Severity and Outcome in Hospitalized Patients
Objectives: This study aimed to measure plasma 25(OH)D3 and DBP in hospitalized COVID-19 cases and assess their correlation with infection severity, inflammatory markers, and clinical outcome.
Original paper ↗Read more →Evaluation of Vitamin D Metabolism in Patients with Type 1 Diabetes Mellitus in the Setting of Cholecalciferol Treatment
All patients received a single dose (150,000 IU) of cholecalciferol aqueous solution orally.
Original paper ↗Read more →Frequencies of CD8 and DN MAIT Cells Among Children Diagnosed With Type 1 Diabetes Are Similar to Age-Matched Controls
Here, we tested the hypothesis that CD8 and double negative (DN) MAIT cell frequencies were altered among diagnosed T1D subjects compared to controls.
Original paper ↗Read more →Influence of vitamin D binding protein polymorphism, demographics and lifestyle factors on vitamin D status of healthy Malaysian pregnant women
Therefore, this cross-sectional study aimed to assess the association between GC gene polymorphism, demographics and lifestyle factors with VDD among Malaysian pregnant women.
Original paper ↗Read more →Isolation of HDL by sequential flotation ultracentrifugation followed by size exclusion chromatography reveals size-based enrichment of HDL-associated proteins
Here we describe a method for isolating HDL particles using a combination of sequential flotation density ultracentrifugation and fast protein liquid chromatography with a size exclusion column.
Original paper ↗Read more →Isotope Coded Protein Labeling analysis of plasma specimens from acute severe dengue fever patients
Dengue fever is the most important arthropod born viral disease of public health significance.
Original paper ↗Read more →Plasma-based proteomic profiling identifies the distinct regulation of proteins in hyperplasia and endometrial cancer
Among gynaecological malignancies, endometrial cancer (EC) is the most prevalent type of uterine cancer affecting women.
Original paper ↗Read more →Pre-analytical stability of the plasma proteomes based on the storage temperature
This study examined the effect of storage temperature on the protein profile of human plasma.
Original paper ↗Read more →Prevalence of vitamin D deficiency in women from southern Brazil and association with vitamin D-binding protein levels and GC-DBP gene polymorphisms
The aim of this study was to assess the prevalence of 25-hydroxyvitamin D [25(OH)D] deficiency and to ascertain whether it is associated with DBP levels and with GC gene variants.
Original paper ↗Read more →rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility
Solar radiation should be avoided in melanoma patients.
Original paper ↗Read more →The Role of Vitamin D in Reproductive Health: A Trojan Horse or the Golden Fleece?
In the last decade, vitamin D was in the spotlight in many fields of research.
Original paper ↗Read more →Upregulation of Irisin and Vitamin D-Binding Protein Concentrations by Increasing Maternal 25-Hydrovitamin D Concentrations in Combination with Specific Genotypes of Vitamin D-Binding Protein Polymorphisms
We aimed to investigate the potential effects of maternal and neonatal VDBP polymorphisms on adiponectin, irisin, and VDBP concentrations at birth, according to different cut-offs of vitamin D status, in maternal: neonatal dyads recruited from the sunny region of Northern Greece.
Original paper ↗Read more →Upregulation of vitamin D-binding protein is associated with changes in insulin production in pancreatic beta-cells exposed to p,p′-DDT and p,p′-DDE
Persistent organochlorine pollutants (POPs) gradually accumulate in the human organism due to their presence in the environment.
Original paper ↗Read more →Vitamin D-binding protein in cervicovaginal fluid as a non-invasive predictor of intra-amniotic infection and impending preterm delivery in women with preterm labor or preterm premature rupture of membranes
This was a single-center retrospective cohort study.
Original paper ↗Read more →Vitamin D-Binding Protein in Pregnancy and Reproductive Health
Improved methods for measuring VDBP and an increased understanding of its role in biological processes have led to a number of newly published studies exploring VDBP in the context of pregnancy.
Original paper ↗Read more →Vitamin D Metabolites: Analytical Challenges and Clinical Relevance
Recent research activities have provided new insights in vitamin D metabolism in various conditions.
Original paper ↗Read more →Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients
These SNPs genotypes, haplotypes and linkage disequilibrium analyses were examined in 299 Egyptian individuals (100 HCV-cirrhotic patients, 99 HCC: HCV patients, and 100 healthy controls).
Original paper ↗Read more →Original sources
Sollid ST, Hutchinson MYS, Berg V, et al. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. European Journal of Endocrinology. 2016;174:445-452.
Sollid ST, Hutchinson MYS, Berg V, et al.
Publication details
Sollid ST, Hutchinson MYS, Berg V, et al. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. European Journal of Endocrinology. 2016;174:445-452.
Hoofnagle AN, Eckfeldt JH, Lutsey PL. Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry. New England Journal of Medicine. 2015;373:1480-1482.
Hoofnagle AN, Eckfeldt JH, Lutsey PL.
Publication details
Hoofnagle AN, Eckfeldt JH, Lutsey PL. Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry. New England Journal of Medicine. 2015;373:1480-1482.
Denburg MR, Hoofnagle AN, Sayed S, et al. Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes. Journal of Bone and Mineral Research. 2016;31:1128-1136.
Denburg MR, Hoofnagle AN, Sayed S, et al.
Publication details
Denburg MR, Hoofnagle AN, Sayed S, et al. Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes. Journal of Bone and Mineral Research. 2016;31:1128-1136.
Nielson CM, Jones KS, Chun RF, et al. Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations. Journal of Clinical Endocrinology and Metabolism. 2016;101:2226-2234.
Nielson CM, Jones KS, Chun RF, et al.
Publication details
Nielson CM, Jones KS, Chun RF, et al. Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations. Journal of Clinical Endocrinology and Metabolism. 2016;101:2226-2234.
Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. Journal of Clinical Investigation. 1986;78:748-752.
Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG.
Publication details
Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. Journal of Clinical Investigation. 1986;78:748-752.
Henderson CM, Fink SL, Bassyouni H, et al. Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene. New England Journal of Medicine. 2019;380:1150-1157.
Henderson CM, Fink SL, Bassyouni H, et al.
Publication details
Henderson CM, Fink SL, Bassyouni H, et al. Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene. New England Journal of Medicine. 2019;380:1150-1157.